
Serostim’s Role in Managing Cachexia Among American Male Cancer Patients
Reading Time: 2 minutes Introduction to Cachexia and Its Impact on Cancer Patients Cachexia, a debilitating syndrome characterized by severe weight loss, muscle atrophy, and loss of appetite, is a prevalent issue among cancer patients, particularly affecting American males. This condition not only diminishes the quality of life but also significantly impacts the prognosis and treatment outcomes. In the quest to mitigate the effects of cachexia, Serostim, a recombinant human growth hormone, has emerged as a potential therapeutic agent. Understanding Serostim: Mechanism of Action Serostim, generically known as somatropin, is a biosynthetic form of human growth hormone that has been approved by the FDA...